Unsere Internetseite verwendet Cookies. Indem Sie weiter auf unserer Website navigieren, stimmen Sie der Verwendung von Cookies zu. Mehr Informationen finden Sie in unserer Datenschutzerklärung.

Pressemitteilungen

Gen Re Announces 2017 U.S. Group Term Life Market Survey Results

Ausgabe: June 2018 | Life/Health North America

For immediate release
June 4, 2018

Portland, ME, June 4, 2018 … Gen Re has released results of its 2017 U.S. Group Term Life Market Survey. This annual industry benchmark survey covers Group Term Life and Accidental Death & Dismemberment (AD&D) in-force and new sales results for the U.S. market, representing combined employer-paid and employee-paid business.

According to the participating companies (25 for Group Term Life; 23 for AD&D), sales and in-force premium growth was positive for both products. Key observations include:

  • Participants reported $24.5 billion in total Group Term Life in-force premium, a 4% increase compared to 2016 results.
  • The total number of employers offering coverage remained flat from year-to-year, while the number of insured employees grew by 4%.
  • In-force premium for Group AD&D was up at a moderate pace of 7%. The gain for new AD&D sales premium was more significant at 15%.
  • New Group Term Life sales premium growth was positive for the third year in a row, posting a healthy 12% increase to reach $2.7 billion.
  • At $94,835, the average face amount for new Group Term Life policies was up by 12% in 2017.
     

The full results of the Market Survey is available only to participating companies. A summary report is available online at www.genre.com/lhsurveys.

________________________

Gen Re, a Berkshire Hathaway Company, is one of the leading life/health and property/casualty reinsurers in the world. Our North American life and health reinsurance company, General Re Life Corporation, has superior financial strength ratings among life and health reinsurers. Gen Re delivers tailor-made reinsurance programs and risk management solutions for the Life, AD&D, Medicare Supplement, Critical Illness and Disability markets. Through our research, we also offer valuable information and insights. For more information, visit www.genre.com.

 

Contact:

Mike Fullerton
Tel. + 1 207 347 4636